How to take Pemetinib (pemetinib) and how much to use
Pemetinib (pemetinib) is an innovative targeted therapy drug that brings new treatment options to cancer patients withFGFR gene mutations, especially those with cholangiocarcinoma. This drug effectively inhibits the proliferation of tumor cells by inhibiting the activity of fibroblast growth factor receptor (FGFR).
Regarding the taking method and dosage of pemetinib, first of all, it needs to be clear that this is an oral drug and its use should be strictly followed by the doctor's instructions. Generally speaking, the recommended dose of pemetinib is 13.5 mg per day, which should be taken orally in one go. Patients should take it at a fixed time every day to ensure stable drug levels in the body, either before or after meals.

The treatment plan for taking pemetinib usually includes continuous administration for 14 days followed by 7 days of discontinuation, thus forming a complete 21-day treatment cycle. During treatment, patients should swallow the tablets whole and avoid chewing, crushing or dissolving them to ensure the sustained release effect and stable drug concentration in the body.
If the patient misses a dose while taking the medicine, and it has been more than 4 hours before the next dose, there is no need to take a supplementary dose, just skip the dose and continue taking the next dose according to the normal schedule. It is important that patients avoid drinking alcohol while taking this medication, as alcohol may affect the metabolism and efficacy of the medication.
While taking pemetinib, patients may experience some side effects, such as nausea, vomiting, diarrhea, fatigue, etc. These side effects are usually predictable and manageable, but if symptoms persist or worsen, you should contact your doctor immediately.
In general, the taking method and dosage of pemetinib are based on the patient's specific situation and the doctor's recommendations. Proper administration and dosage are crucial to ensure the efficacy and safety of the drug. Therefore, when taking pemetinib, patients must strictly follow the doctor's instructions, pay attention to their physical condition, and adjust the treatment plan in a timely manner.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)